Solventum SOLV MedSurg — Total operating income

Other segment segments

Similar metrics at other companies

BSXMedSurg — Segment operating income, percentage of net sale

31.3%-2.0pp

BSXMedSurg — Operating Income (Loss), Adjusted

$533M-0.6%

BSXMedSurg — Cost of products sold, percentage of net sale

28.1%+1.1pp

BSXMedSurg — Selling, general and administrative expenses

$557M+8.8%

BSXMedSurg — Net sales of reportable segments

$1.7B+5.7%

BSXMedSurg — Selling, general and administrative expenses, percentage of net sale

32.8%+1.0pp

Questions, answered.

What is Solventum's medsurg — total operating income?

Solventum (SOLV) reported medsurg — total operating income of $161M in Q1 2026.

How has Solventum's medsurg — total operating income changed year-over-year?

Solventum's medsurg — total operating income decreased by 21.8% year-over-year, from $206M to $161M.

What is the long-term trend for Solventum's medsurg — total operating income?

Over 3 years (2022 to 2025), Solventum's medsurg — total operating income has grown at a -8.6% compound annual growth rate (CAGR), from $1.06B to $810M.

What does medsurg — total operating income mean?

The profit earned from MedSurg operations before interest and taxes.

How do you interpret medsurg — total operating income?

Higher operating income indicates strong profitability and effective management of both production and overhead costs.

How does medsurg — total operating income compare across companies?

Standard operating profit metric used across all industries to assess segment-level performance.